Gabrielle joined the team in 2023. She initially trained as a biochemist and subsequently completed her PhD in molecular and microbiology from the University of Birmingham. Previously, Gabrielle has worked on altering bacterial genomes to prevent expression of virulence determinants and to resurrect sensitivity to antibiotics.